Nathaniel E. David, Director at KYTHERA BIOPHARMACEUTICALS INC (KYTH), sold 1,875 shares at $41.67 ($76K) on 2015-03-02, disclosed to the SEC on 2015-03-03.
Scheduled sale ($76k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.95 | 1,175 | $47K | 61.4% |
| 2 | $41.67 | 400 | $17K | 21.8% |
| 3 | $42.80 | 300 | $13K | 16.8% |
| Total | $40.77 avg | 1,875 | $76K | 100% |
| Filing → |
| KYTH | SELL | 2015-03-10 | $340K | — | Filing → |
| KYTH | SELL | 2015-03-05 | $600K | — | Filing → |
| KYTH | SELL | 2015-02-19 | $32K | — | Filing → |